| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
IKBKE |
IKBKE, IKKE, IKKI, KIAA0151: Inhibitor of nuclear factor kappa-B kinase subunit |
4.197 |
Evidence |
|
| ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
PHLDB2 |
PHLDB2, LL5B: Pleckstrin homology-like domain family B member 2 |
4.197 |
Evidence |
|
| HDAC3 |
HDAC3: Histone deacetylase 3 |
SIN3A |
SIN3A: Paired amphipathic helix protein Sin3a |
4.197 |
Evidence |
|
| CTBP1 |
CTBP1, CTBP: C-terminal-binding protein 1 |
TRERF1 |
TRERF1, BCAR2, RAPA, TREP132: Transcriptional-regulating factor 1 |
4.197 |
Evidence |
|
| RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
4.197 |
Evidence |
|
| RGS7 |
RGS7: Regulator of G-protein signaling 7 |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
4.197 |
Evidence |
|
| PDPK1 |
PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 |
TH |
TH, TYH: Tyrosine 3-monooxygenase |
4.197 |
Evidence |
|
| TAOK1 |
TAOK1, KIAA1361, MAP3K16: Serine/threonine-protein kinase TAO1 |
EPB41L1 |
EPB41L1, KIAA0338: Band 4.1-like protein 1 |
4.197 |
Evidence |
|
| EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
4.197 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
4.197 |
Evidence |
|
| PDPK1 |
PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 |
IKBKE |
IKBKE, IKKE, IKKI, KIAA0151: Inhibitor of nuclear factor kappa-B kinase subunit |
4.197 |
Evidence |
|
| SIN3A |
SIN3A: Paired amphipathic helix protein Sin3a |
BAZ2A |
BAZ2A, KIAA0314, TIP5: Bromodomain adjacent to zinc finger domain protein 2A |
4.197 |
Evidence |
|
| AKT1 |
AKT1, PKB, RAC: RAC-alpha serine/threonine-protein kinase |
IKBKE |
IKBKE, IKKE, IKKI, KIAA0151: Inhibitor of nuclear factor kappa-B kinase subunit |
4.197 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
4.197 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
PLK1 |
PLK1, PLK: Serine/threonine-protein kinase PLK1 |
4.195 |
Evidence |
|
| C1QBP |
C1QBP, GC1QBP, HABP1, SF2P32: Complement component 1 Q subcomponent-binding prot |
MKNK1 |
MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 |
4.195 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
PHC2 |
PHC2, EDR2, PH2: Polyhomeotic-like protein 2 |
4.195 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
PTPRE |
PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor |
4.195 |
Evidence |
|
| FIGF |
FIGF, VEGFD: Vascular endothelial growth factor D precursor |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
4.195 |
Evidence |
|
| MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
C1QBP |
C1QBP, GC1QBP, HABP1, SF2P32: Complement component 1 Q subcomponent-binding prot |
4.195 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
C1QBP |
C1QBP, GC1QBP, HABP1, SF2P32: Complement component 1 Q subcomponent-binding prot |
4.195 |
Evidence |
|
| C1QBP |
C1QBP, GC1QBP, HABP1, SF2P32: Complement component 1 Q subcomponent-binding prot |
RPS6KA2 |
RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 |
4.195 |
Evidence |
|
| KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
SOS1 |
SOS1: Son of sevenless homolog 1 |
4.187 |
Evidence |
|
| AKAP1 |
AKAP1, AKAP149, PRKA1: A kinase anchor protein 1, mitochondrial precursor |
CSTF2T |
CSTF2T, KIAA0689: Cleavage stimulation factor 64 kDa subunit, tau variant |
4.187 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
IQGAP2 |
IQGAP2: Ras GTPase-activating-like protein IQGAP2 |
4.187 |
Evidence |
|
- 
-